Anxiety Risk and Your Genetics

Anxiety Risk

Anxiety risk is a measure of genetic susceptibility to anxiety disorders — among the most prevalent mental health conditions worldwide. Large-scale genomic research has identified hundreds of independent genomic regions associated with anxiety-related traits, including neuroticism facets such as worry and depressed affect.[¹] This page covers what the science currently understands about genetic contributions to anxiety, which genes have been implicated, and how to work with your results.

What is Anxiety Risk?

Anxiety disorders encompass a broad spectrum of conditions characterized by persistent, excessive worry, fear, or nervousness that interferes with daily functioning. From generalized anxiety disorder to panic disorder and social anxiety, these conditions share an underlying neurobiology shaped by both environment and genetics.

Genetics does not determine whether you will experience anxiety — it contributes to a baseline susceptibility that interacts with life experience, stress exposure, sleep, and social support. Research frames anxiety risk as polygenic: many genetic variants, each with a small effect, combine across the genome to influence overall susceptibility. Understanding your genetic profile offers one piece of a much larger picture.

255 independent genomic regions were identified in a large-scale study examining individual neuroticism items, including worry — demonstrating the complex, polygenic architecture underlying anxiety-related traits.[¹]

The genetics behind Anxiety Risk

The genetic architecture of anxiety overlaps substantially with broader neuroticism — a personality dimension encompassing emotional instability, worry, and vulnerability to stress. Research examining neuroticism at the level of individual questionnaire items, rather than composite scores, has uncovered striking genetic heterogeneity: the genetic factors driving worry are partly distinct from those driving depressed affect, with genetic correlations between individual items ranging from 0.38 to 0.91.[¹]

Several genes have emerged from genome-wide analyses as candidates near signals associated with anxiety-related traits. CADM2 (Cell Adhesion Molecule 2) is involved in synaptic organization and has shown one of the stronger genomic signals in this space. CELF4 (CUGBP Elav-like Family Member 4) plays a role in RNA processing in neurons and has been implicated in neurodevelopmental contexts. YLPM1 is expressed in the brain and has been associated with neuroticism-related phenotypes in large genomic studies.

Other genes in the authorized evidence set for this trait include AGBL2, DENND1A, DLST, MADD, MC4R, NUP160, and PTPRJ — each identified near genomic signals in studies of anxiety-related neuroticism phenotypes. The functional pathways connecting these genes to anxiety biology span synaptic signaling, neuronal RNA regulation, and cellular processes in brain tissue.

Because many of these signals sit near — rather than within — the genes themselves, the link between variant and mechanism often requires additional experimental work to confirm. This is characteristic of complex polygenic traits: the genome points toward biological neighborhoods, and researchers work to map the specific functional mechanisms from there.

Two genetically distinct clusters — depressed affect and worry — emerged from item-level genomic analysis of neuroticism, suggesting anxiety-related susceptibility has separable genetic components rather than a single unified architecture.[¹]

What the research says

Research base: moderate.

The primary evidence for this trait comes from a large-scale genome-wide association study by Nagel and colleagues (2018), which analyzed 12 individual neuroticism questionnaire items across samples of European descent.[¹] By moving beyond composite neuroticism scores to item-level analysis, the study identified 255 genome-wide significant independent genomic regions — of which 138 were specific to individual items rather than shared across all facets. This methodological advance revealed that worry and depressed affect, while correlated, have partly distinct genetic architectures.

The study's findings established that studying neuroticism at a granular level improves biological resolution. Genetic correlations between items ranged from 0.38 to 0.91, confirming both overlap and divergence among anxiety-related neuroticism facets. This kind of item-level dissection is increasingly applied in psychiatric genomics to parse heterogeneous conditions into biologically more coherent subtypes.

See our methodology page for how ExomeDNA assesses genetic evidence.

It is worth noting that the current evidence base is primarily derived from populations of European descent, which limits generalizability. Future research in more diverse populations will be important for establishing whether the same genomic regions and effect sizes replicate broadly.

How Anxiety Risk affects you

Genetic susceptibility to anxiety does not operate in isolation. The same gene variants that appear in large population studies are present in people who never develop a clinical anxiety disorder, as well as in people who do. Environment — childhood experiences, chronic stress, social factors, physical health — interacts with genetic predisposition in ways that current science cannot fully model at the individual level.

For a trait where higher scores reflect elevated susceptibility, the practical implication is awareness rather than alarm. People with a higher genetic score may benefit from strategies that are known to support emotional regulation more broadly: consistent sleep, regular physical activity, strong social connections, and proactive stress management. None of these replace clinical evaluation or treatment when anxiety significantly affects quality of life.

Genetics also informs the biological dimension of treatment response — an area of active research. Understanding that anxiety has a heritable, neurobiological component can reduce self-stigma and support informed conversations with healthcare providers.

Working with your Anxiety Risk profile

Your genetic profile for anxiety susceptibility is one input among many. Here is how to use it constructively:

Understand the scope. A higher score means the genetic variants associated with anxiety susceptibility are more prevalent in your genome. It does not mean anxiety is inevitable, nor does it quantify your absolute lifetime risk.

Focus on modifiable factors. Physical activity, sleep quality, mindfulness practices, and social engagement all have evidence-based support for reducing anxiety symptoms. These interventions are relevant regardless of genetic score.

Use it as a conversation starter. Anyone with concerns about anxiety — regardless of genetic score — has good reason to speak with a qualified healthcare provider. Your genetic profile can provide useful context but is not a substitute for professional evaluation.

Track related traits. Anxiety susceptibility shares genetic overlap with other traits, including sleep quality and stress reactivity. Reviewing related profiles in your ExomeDNA report can give a more complete picture of your neurobiological landscape.

Related traits and genes

Anxiety susceptibility sits within a broader cluster of mental health and behavioral traits that share genetic architecture. In your ExomeDNA report, related Mental Health traits include Neuroticism, Stress Reactivity, and Depression Risk — each capturing overlapping but partially distinct dimensions of emotional vulnerability.

Cross-category connections extend to Sleep & Circadian traits (poor sleep quality is both a symptom and a risk factor for anxiety) and Cognitive traits, where attention and working memory share biological pathways with anxiety-related neuroticism.

The gene CADM2 — among the strongest genomic signals associated with this trait — is also implicated in broader behavioral and cognitive phenotypes, illustrating how individual genes often participate in multiple neurobiological systems. You can explore more about CADM2 and related synaptic genes on the CADM2 gene page.

Internal links for further reading:

• Neuroticism genetic profile
• Stress Reactivity genetic profile
• Depression Risk genetic profile
• Sleep Quality genetic profile
• Cognitive Resilience genetic profile

Frequently asked questions

Q: Does a higher Anxiety Risk score mean I have an anxiety disorder? A: No. Your score reflects the relative presence of genetic variants associated with anxiety susceptibility in large population studies. Many people with higher scores never develop an anxiety disorder, and many people with anxiety disorders have average or lower genetic scores. Genetics is one contributing factor among many.

Q: Which genes are linked to my Anxiety Risk result? A: Several genes near genomic signals for anxiety-related neuroticism traits are included in this profile, including CADM2, CELF4, YLPM1, AGBL2, DENND1A, DLST, MADD, MC4R, NUP160, and PTPRJ. These genes were identified in genome-wide studies of neuroticism facets such as worry. Their biological roles span synaptic organization, RNA regulation in neurons, and other brain-relevant processes.

Q: How confident is the science behind this trait? A: The confidence tier for this trait is moderate. The evidence comes from a well-powered genome-wide study identifying 255 independent genomic regions for neuroticism items, including worry.[¹] The science is meaningful but the field is still working to translate population-level signals into precise individual-level predictions.

Q: Can I reduce my genetic susceptibility to anxiety? A: Genetic variants themselves do not change, but their influence on anxiety outcomes is substantially modifiable through environment and behavior. Regular physical activity, consistent sleep, stress management practices, and social support all have evidence-based roles in reducing anxiety symptoms. Speaking with a healthcare provider is the best starting point if anxiety is affecting your daily life.

Q: Why is anxiety risk described as polygenic? A: Polygenic means that many genetic variants — each with a small effect — combine to influence susceptibility. Rather than a single gene "causing" anxiety, hundreds of genomic regions each contribute a tiny amount. This is why genome-wide studies of anxiety-related traits have identified signals across 255 or more independent regions.[¹]

Q: Is this trait the same as a clinical anxiety assessment? A: No. This trait measures genetic susceptibility informed by population genomics research. It is a research-derived score, not a clinical evaluation. Only a qualified healthcare provider can conduct a clinical assessment of anxiety.

References

[1] Nagel M, Watanabe K, Stringer S, Posthuma D, van der Sluis S. Item-level analyses reveal genetic heterogeneity in neuroticism. Nature Communications. 2018;9(1):905. DOI: 10.1038/s41467-018-03242-8. PMID: 29500382.

Data sources: GWAS Catalog | ClinVar | ClinGen

By the ExomeDNA Research Team